Dashboard
Manage Tickers

CC


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

wall-streets-most-accurate-analysts-give-their-take-on-3-materials-stocks-delivering-high-dividend-yields
Wall Street's Most Accurate Analysts Give ...
09/11/2024 12:26:01

chemours-develops-cost-effective-retrofit-for-r-134a-refrigerant-in-cars-supporting-global-phasedown
Chemours Develops Cost-Effective Retrofit ...
09/09/2024 10:46:38

The Chemours Company (Chemours) (NYSE:CC), a global leader in delivering innovative performance chemistry, today announced the ...

breaking-down-chemours-7-analysts-share-their-views
Breaking Down Chemours: 7 Analysts Share T...
09/03/2024 15:00:42

goldman-sachs-maintains-neutral-on-chemours-lowers-price-target-to-23
Goldman Sachs Maintains Neutral on Chemour...
09/03/2024 13:34:51

Goldman Sachs analyst Duffy Fischer maintains Chemours (NYSE:CC) with a Neutral and lowers the price target from $29 to $23.

how-is-the-market-feeling-about-chemours
How Is The Market Feeling About Chemours?
08/28/2024 19:45:21

wall-streets-most-accurate-analysts-spotlight-on-3-materials-stocks-delivering-high-dividend-yields
Wall Street's Most Accurate Analysts Spotl...
08/28/2024 12:58:26

the-chemours-company-opens-chemours-battery-innovation-center-at-newark-delaware-focused-on-testing-and-scaling-next-generation-battery-technologies-for-sustainable-cost-effective-and-high-performing-ev-batteries
The Chemours Company Opens Chemours Batter...
08/13/2024 20:28:53

 Multi-Million-Dollar Investment Supports Hybrid And Electric Vehicle Advancements

jp-morgan-maintains-neutral-on-chemours-lowers-price-target-to-18
JP Morgan Maintains Neutral on Chemours, L...
08/06/2024 16:12:12

JP Morgan analyst Jeffrey Zekauskas maintains Chemours (NYSE:CC) with a Neutral and lowers the price target from $25 to $18.

ubs-maintains-buy-on-chemours-lowers-price-target-to-28
UBS Maintains Buy on Chemours, Lowers Pric...
08/06/2024 15:34:39

UBS analyst Joshua Spector maintains Chemours (NYSE:CC) with a Buy and lowers the price target from $30 to $28.

the-analyst-landscape-4-takes-on-chemours
The Analyst Landscape: 4 Takes On Chemours
08/06/2024 14:00:48

barclays-maintains-equal-weight-on-chemours-lowers-price-target-to-22
Barclays Maintains Equal-Weight on Chemour...
08/06/2024 13:12:04

Barclays analyst Michael Leithead maintains Chemours (NYSE:CC) with a Equal-Weight and lowers the price target from $30 to $22.

bmo-capital-maintains-outperform-on-chemours-lowers-price-target-to-30
BMO Capital Maintains Outperform on Chemou...
08/06/2024 11:54:16

BMO Capital analyst John McNulty maintains Chemours (NYSE:CC) with a Outperform and lowers the price target from $35 to $30.

the-chemours-company-anticipates-a-low-to-mid-single-digit-sequential-decline-in-net-sales-for-q3
The Chemours Company Anticipates A Low To ...
08/01/2024 20:28:48

OutlookThe Company anticipates a low to mid-single digit sequential decline in Net Sales for the third quarter, reflective of:R...

chemours-q2-adj-038-misses-057-estimate-sales-154b-beat-153b-estimate
Chemours Q2 Adj $0.38 Misses $0.57 Estimat...
08/01/2024 20:28:01

Chemours (NYSE:CC) reported quarterly earnings of $0.38 per share which missed the analyst consensus estimate of $0.57 by 33.33...

wall-streets-most-accurate-analysts-views-on-3-materials-stocks-delivering-high-dividend-yields
Wall Street's Most Accurate Analysts' View...
08/01/2024 13:55:36

ubs-upgrades-chemours-to-buy-raises-price-target-to-30
UBS Upgrades Chemours to Buy, Raises Price...
07/09/2024 12:56:44

UBS analyst Joshua Spector upgrades Chemours (NYSE:CC) from Neutral to Buy and raises the price target from $28 to $30.

reported-earlier-chemours-company-announced-that-the-mexican-government-has-lifted-its-prior-water-intake-restrictions-enabling-the-company-to-resume-normal-operations-at-its-titanium-dioxide-tio2-manufacturing-facility-in-altamira-mexico
Reported Earlier, Chemours Company Announc...
06/25/2024 06:55:05

how-is-the-market-feeling-about-chemours
How Is The Market Feeling About Chemours?
06/20/2024 18:00:25

what-analysts-are-saying-about-chemours-stock
What Analysts Are Saying About Chemours Stock
06/07/2024 13:00:23

mizuho-initiates-coverage-on-chemours-with-neutral-rating-announces-price-target-of-25
Mizuho Initiates Coverage On Chemours with...
06/07/2024 10:40:46

Mizuho analyst John Roberts initiates coverage on Chemours (NYSE:CC) with a Neutral rating and announces Price Target of $25.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION